Impairment of the suppressive function of regulatory T (T reg ) cells has been reported in myasthenia gravis (MG). In this study, cytokine-related mechanisms that may lead to the defect of T reg were investigated in patients with anti-acetylcholine receptor antibody-positive MG (AChR 1 MG). Proliferation and cytokine production of responder T (T resp ) cells in response to polyclonal activation were measured in a suppression assay. The effect of interleukin (IL)-21 on suppression was evaluated in vitro in coculture. IL-21 increased the proliferation of T resp cells in T resp /T reg cocultures. T resp cells from patients with MG secreted significantly lower levels of IL-2. In patients with MG, IL-2 levels did not change with the addition of T reg to cultures, whereas it decreased significantly in controls. In T resp /T reg co-cultures, IL-4, IL-6 and IL-10 production increased in the presence of T reg in patients. Interferon (IFN)-g was decreased, whereas IL-17A was increased in both patient and control groups. IL-21 inhibited the secretion of IL-4 in MG and healthy controls (HC), and IL-17A in HC only. The results demonstrated that IL-21 enhances the proliferation of T resp cells in the presence of T reg . An effect of IL-21 mainly on T resp cells through IL-2 is implicated.
Introduction

CD4
1 CD25 1 regulatory T cells (T reg ) are an essential component in the counterbalance of the autoimmune response by regulating the activation, proliferation and cytokine production of autoreactive cells [1] . CD4 1 CD25 1 T reg cells express the transcription factor, forkhead box P3 (FoxP3), which is essential for their functional activity [2, 3] . The mechanisms used by T reg cells to mediate suppression include both cytokines as well as cell-surface molecules. Myasthenia gravis (MG) is the most common humoral and cellular immune-mediated neuromuscular disorder, caused by autoantibodies against the acetylcholine receptor (AChR 1 MG) of skeletal muscles [4] . It has been demonstrated that T reg cells from the thymus and peripheral blood of patients with AChR 1 MG have a severe defect in their suppressive function, which suggests a role for T reg abnormalities in MG pathogenesis [5] [6] [7] [8] . Previously, we have shown that the observed abnormalities of T reg cells from patients with AChR 1 MG might be related to altered expression of co-stimulatory/co-inhibitory molecules leading to instable interaction between T reg , responding T (T resp ) and antigen-presenting cells (APC). Additionally, the impairment of T reg cells was associated with an intracellular decrease of expression of FoxP3 and phosphorylation of signal transducer and activator of transcription-5 (STAT-5) [5] . Inefficient regulation of cytokine secretion by T reg cells from MG patients was also reported [8] . However, the T reg dysfunction still needs further explanation related to cytokines that exist in serum or produced by immune cells.
Abnormal cytokine networks affecting the balance of T helper type 1 (Th1), Th2 and Th17 cell subsets have been shown in the pathogenesis of MG [9] [10] [11] [12] [13] . Some proinflammatory cytokines, such as tumour necrosis factor (TNF)-a and interleukin (IL)-21, can also interfere with T reg function [14, 15] . IL-21, a relatively new pleiotropic cytokine, plays a crucial role in the generation of Th-mediated immune responses in inflammatory diseases characterized by defects of counter-regulatory mechanisms [16] . It has been reported that IL-21 is able to enhance the generation of Th2, Th17 and T follicular helper (Tfh) cells and B cells, and limit the differentiation of Th1 and T reg cells [17] . Increased expression of IL-21 and/or its receptor, IL-21R, has been documented in inflammatory diseases [18] [19] [20] . Recently, augmented activity of Tfh cells from patients with MG has been reported to promote B cells to produce autoantibodies in an IL-21-dependent manner [21] . Furthermore, higher serum IL-21 has also been reported in patients with MG in comparison with healthy controls [22] .
Based on this background, the diminished ability of T reg cells to inhibit T cell proliferation documented in patients with AChR 1 MG raised the possibility that inflammatory stimuli in MG may impair the regulatory properties of T reg cells [5, 8] . As IL-21 may have opposite effects on CD4
1 T cells and T reg cells, we hypothesized that IL-21 may modulate T reg /T cell function and cytokine production in AChR 1 MG. This study aims to understand the function of IL-21 on T cell proliferation isolated from AChR 1 MG patients, and to assess its effects on cytokine responses in purified T resp /T reg co-cultures. The effects of T reg cells on the production of cytokines, which are induced upon polyclonal T cell receptor (TCR) stimulation of T resp cells, were also analysed.
Materials and methods
Patients and controls
Peripheral blood samples were obtained from 20 patients with generalized AChR 1 MG (13 men and seven women, mean age 5 48 6 17Á9 years) and 20 healthy controls (HC) (12 men and eight women, mean age 5 46Á7 6 14Á7 years). The diagnosis of MG was based on clinical presentation, electrophysiological examination and the presence of antiAChR antibodies. Representing the disease heterogeneity, patients with early-onset (< 50 years, n 5 8) and late-onset (> 50 years, n 5 12) disease were included in the patient group. Of the patients, 60% underwent thymectomy, six patients had thymic hyperplasia and none had thymoma. At the time of the study, 70% of the patients were on immunosuppressive (IS) therapy (steroid alone or steroid plus azathioprine). The HC were matched for sex and age with the patients (12 men, eight women, mean age 5 476 14Á7 years). The Ethics Committee of Istanbul Medical Faculty approved the study and a written informed consent was obtained from all donors. ) cells were identified further by the intracellular FoxP3 staining and more than 80% of these cell populations from the patients and HC were positive [5] .
Isolation of T cell subsets
Cell proliferation measurement
Isolated T resp cells were labelled with carboxyfluorescein diacetate succinimidyl ester (CFSE, final concentration: 2 lM; Sigma, St Louis, MO, USA), as described previously [5] . The proliferation of labelled cells was assessed by evaluating the percentage of cells with decreased CFSE intensity.
Stimulation of cells and suppression assay
T reg /T resp suppression assays were performed for 4 days, as described previously [5] . Alternatively, suppression assay was assessed using CFSE-stained T resp (7 3 10 4 cells/well) incubated with T reg cells (T reg : T resp ratio, 0Á5 : 1), stimulated by anti-CD3 [OKT3 for cell culture; Biolegend] and recombinant (r)IL-21 (50 ng/ml; Peprotech, Rocky Hill, NJ, USA) in the presence of APC (1 3 10 5 cells/well) for 4 days. Assays were performed at 378C in an atmosphere with 5% CO 2 in cell culture medium. Stimulation of T resp cells alone was performed using CFSE under the same stimulation conditions, without the addition of T reg cells. Data were acquired using a FACSCalibur and analysed using CellQuest software (BD). The cell culture supernatant was stored at 2808C and used to measure cytokines. RPMI-1640 supplemented with 1% sodium pyruvate (GIBCO, Carlsbad, CA, USA), 2 mM L-glutamine (GIBCO), 10 000 U/ml penicillin (GIBCO), 100 mg/ml streptomycin (Sigma) and 10% heat-inactivated fetal bovine serum (GIBCO) was used as culture medium.
Analysis of cytokine production
IL-6, IL-10, IL-17A, IL-4, IL-2 and interferon (IFN)-g were analysed in culture supernatants using a custom-made 6-plex kit (MILLIPLEX MAP; Millipore Corporation, Billerica, MA, USA). Cytokine analysis was performed according to the manufacturer's instructions.
Statistical analysis
Non-parametric tests (Mann-Whitney U and Wilcoxon) were used to evaluate differences between groups. A Pvalue of less than 0Á05 was considered significant. All statistical analyses were performed with SPSS software version 21Á0 and graphs were drawn by GraphPad Prism software version 6Á07 (San Diego, CA, USA).
Results
IL-21 enhanced the proliferation of T resp only in the presence of T reg cells
We have demonstrated previously that CD4 1 CD25 11 T reg cells from patients with AChR 1 MG exhibited a severe defect in the immunosuppression assay. To assess the effect of IL-21 on T reg -mediated immunosuppression, T reg and T resp cells were stimulated with anti-CD3 in the presence and absence of IL-21 for 4 days, and the proliferation of T resp cells was analysed using a CFSE-based assay. Figure 1a demonstrates representative plots in a patient with AChR 1 MG and an HC indicating that IL-21 can enhance the proliferation of T resp in the presence of T reg cells. The addition of IL-21 to the co-culture of T reg and T resp (ratio 0Á5 : 1) cells increased the proliferation of T resp in both AChR 1 MG (P 5 0Á002) and HC (P < 0Á001) groups significantly (Fig. 1b) . The effect of IL-21 in T cell cocultures was also compared with the ratios of proliferation (proliferation in co-culture with IL-21/proliferation in coculture) in patients with AChR 1 MG and HC. The increase in IL-21-associated proliferation was lower in patients with AChR 1 MG than HC (P 5 0Á014) (Fig. 1c) . However, IL-21 did not induce higher proliferation on isolated T resp cultures (Fig. 1d) . These data indicate that T (T reg ) cells from patients with AChR 1 MG were less responsive to in-vitro IL-21.
The effects of IL-21 on cytokine production in T reg and T resp co-culture
The observed defect of T reg suppression in patients with AChR 1 MG may have reflected the ability of IL-21 to alter cytokine production in vivo. We next assessed the possible mechanisms of immune regulatory dysfunction in AChR 1 MG by examining profiles of cytokine secretion in the cell-free culture supernatants with or without rIL-21. For possible effects on regulation of autoantibody production, IL-2, IL-4, IL-6, IL-17A, IL-10 and IFN-g were measured in the proliferation/suppression assays performed with anti-CD3 polyclonal activation in patients with AChR 1 MG and HC. The addition of T reg cells to the T resp cell cultures changed most of the cytokines measured in the co-cultures. IFN-g levels were suppressed significantly with the addition of T reg cells in both patients with AChR 1 MG (P 5 0Á005) and HC (P 5 0Á001) (Fig. 2a) . In contrast, IL-17A levels were increased both in patients with AChR 1 MG (P 5 0Á001) and HC (P 5 0Á003) in T resp /T reg co-cultures compared with T resp cultures (Fig. 2a) . However, differential effects of T reg cells were observed in IL-4, IL-10 and IL-6 levels. Significant increases were detected in T resp /T reg cocultures compared to T resp cultures in AChR 1 MG (P 5 0Á005, P 5 0Á008 and P 5 0Á04) (Fig. 2b) . In HC, the levels of these cytokines did not change significantly with the addition of T reg cells. Taken together, T resp cells in coculture with T reg cells from patients with AChR 1 MG secreted higher levels of IL-4, IL-10 and IL-6, consistent with an environment that promotes antibody production. As the T reg -induced cytokine changes were reduced in the untreated group of only six patients, the differences may also be induced by immunosuppressive treatment (data not shown).
Conversely, IL-2 levels decreased significantly with the addition of T reg cells in HC (P 5 0Á01), but not in patients with AChR 1 MG. However, IL-2 levels produced by T resp alone were lower in patients when compared with controls (P 5 0Á04) (Fig. 2c) .
When further analysis was performed with the addition of IL-21 on T reg /T resp co-cultures, IL-21 inhibited the production of IL-4 significantly in both patients with AChR 1 MG (P 5 0Á03) and HC (P 5 0Á01) compared to the IL-21-free conditions (Fig. 3a) . This effect was lower in HC than patients with AChR 1 MG (P 5 0Á046). Conversely, the level of IL-17A decreased significantly with the addition of IL-21 (T resp /T reg co-cultures) in HC (P 5 0Á035), but not in patients with AChR 1 MG (Fig. 3b) . In untreated patients, although very few in number (n 5 6), an increase of IL-17A was observed with the addition of IL-21 (data not shown). No change in IL-2, IL-6, IL-10 and IFN-g was observed with the addition of IL-21 to T reg /T resp co-cultures (data not shown).
Among the cytokines evaluated, IL-2 was the only cytokine produced differentially by T resp cells of patients with AChR 1 MG and HC. T resp cells alone produced significantly lower levels of IL-2 in patients in comparison with controls (P 5 0Á03) (Fig. 2c) . IL-2 levels decreased significantly with the addition of T reg cells in HC (P 5 0Á001) but not in patients. This finding may be related to the lower levels of IL-2 in patients with AChR 1 MG, probably with the in-vivo effect of IL-21 inhibiting IL-2 production and impairing T reg cells [23] .
Discussion
We and other groups have demonstrated previously that the T reg cells have impaired capacity to suppress T resp cells in AChR 1 MG. The functional impairment of these cells was associated with a reduced expression of FoxP3 and decreased phosphorylation of STAT-5 [5, 15] . In the present study, further molecular mechanisms related to cytokine expressions that may underlie T reg dysfunction in AChR 1 MG were investigated. Among the cytokines produced by T resp cells in the cell culture, only IL-2 levels were decreased in patients when compared to controls. The counteracting effect of IL-21 on T reg cell-related suppression on CD4 1 CD25 -T cell proliferation was weaker in patients with AChR 1 MG, possibly by an IL-2 related mechanism acting on T resp cells in vivo. IL-4 and IL-17A were the only cytokines suppressed by IL-21, IL-17A being significant only in HC.
IL-21, a potent immunomodulatory type I cytokine of CD4 1 T and natural killer (NK) T cells, has pleiotropic effects on adaptive immune responses [17] . Previous data indicated that IL-21 counteracted the suppressive activities of CD4 1 CD25 1 T cells markedly on CD4
1
CD25 -T cells without affecting the percentage of FoxP3
1 cells or survival of T reg [16] . Conversely, increased serum levels of IL-21 were reported in AChR 1 MG compared to healthy individuals [21, 22] . Here, we confirmed that IL-21 could increase the proliferation of T resp cells in T resp /T reg coculture in both AChR 1 MG patients and HC. Inhibition of IL-2 from T resp cells has been documented as a mechanism of the counteraction of IL-21 to T reg suppression. Provision of IL-21 abrogated T reg suppression in vitro and in vivo [16, 23] . Whether T reg function was compromised or T cells showed reduced susceptibility to T reg -mediated suppression needs further evaluation. However, these data suggest that immunological protection of peripheral tissue by T reg cells can be modulated by IL-21 [14] . IL-2 is produced mainly by Th cells and is a key cytokine for T reg cell differentiation, survival and function. Notably, competition for IL-2 is an important mechanism for the action of T reg function. Activated T reg cells absorb IL-2 from their surroundings, thereby synergistically hindering the activation of other cells [15, 24] . Conversely, in many individuals with autoimmune disease such as type 1 diabetes, rheumatoid arthritis and systemic lupus erythematosus, IL-2 production is lower compared with healthy individuals [25] . Additionally, low-dose IL-2 specifically expands and activates T reg cell populations and can thus control autoimmune diseases and inflammation [26] . We also observed that IL-2 levels produced by T resp alone were lower in patients with MG compared to controls. Moreover, IL-2 levels decreased significantly with the addition of T reg cells. The poor production of IL-2 (by T resp cells) observed in patients with AChR 1 MG can influence T reg suppression capacity in vivo, as another mechanism for T reg dysfunction.
In a recent report on mice, the counteracting effect of IL-21 on suppression was associated with the inhibition of IL-2 production by conventional T cells. However, IL-21 was unable to substitute for IL-2 in supporting the T reg compartment, thereby demonstrating that IL-21 and IL-2 had overlapping roles in promoting conventional T cell responses, but played distinct roles in controlling T reg homeostasis and function [23] . IL-21 has been shown to activate STAT-3, but not STAT-5, and had no effect on T reg viability, activation or function [27] . Based on these observations, low doses of IL-2 can also be proposed to stimulate T reg function in AChR 1 MG patients, as suggested for other diseases with T reg abnormalities [28] . Nevertheless, further studies are required to provide evidence for the possible use of IL-2 cytokine therapies in vivo.
To understand the probable effect of T reg cells on T resp , T resp cells were cultured with or without T reg and a cytokine profile was determined in supernatants from patients with AChR 1 MG and HC. With the addition of T reg cells, IL-6, IL-10 and IL-4 levels actually increased in patients with AChR 1 MG but not in HC. T reg cells on T resp culture decreased IFN-g levels, whereas IL-17A levels increased in both patients with AChR 1 MG and HC. These data are in line with previously reported effects of T reg cells in MG, supporting some functional alterations in regulating the production of these cytokines by MG T reg cells [8] . Overall, the increase in IL-4, IL-6 and IL-10 levels of T cell culture supernatants suggested that the T reg cells either produced the cytokines themselves or enhanced production of these cytokines by T resp cells to divert the immune response towards Th2. Previous reports based on thymic cells showed that both conventional T and T reg cell-derived factors contributed to the dysfunction in MG [7] . Although unlikely, the differences in cytokines might be caused by the production of T reg , rather than T resp cells. Further investigation of cytokines from T reg cells is warranted, because the production of these cytokines by T resp did not show differences between patients and controls. The addition of IL-21 on T reg /T resp co-culture inhibited the production of IL-4 significantly in both patients with AChR 1 MG and HC. Conversely, IL-17A levels decreased significantly with the addition of IL-21 in HC, but not in patients with AChR 1 MG. IL-21 even revealed an IL-17A-inducing effect in untreated patients (data not shown). The data indicated that T cells from HC were more susceptible to the effect of IL-21 on IL-17A secretion. In-vitro administration of granulocyte-macrophage colony-stimulating factor has also been reported as a means of enhancing suppressive function of T reg cells in MG [29] . With these findings, IL-21 is also proposed as a modulator of T reg on T resp proliferation and cytokine secretion.
With regard to the limitations of the study, the effect of immunosuppressive treatment could not be delineated in some of the observations. Corticosteroid treatment as well as in-vitro application of these drugs, have revealed inhibition of main inflammatory cytokines such as IL-2 and IFNg and sometimes induction of Th2-related cytokines such as IL-4 and IL-10 [30] [31] [32] . Lower IL-2 production of T resp cells as well as the increases in IL-4, IL-6, IL-10 and IL-17A production in co-cultures may be consequences of immunosuppressive treatment, as the increases were not detectable in the small number of untreated patients (data not shown). Similarly, the effect of IL-21 on IL-17A production in the co-cultures may be concealed by the immunosuppressive treatment, as the untreated six patients had relatively higher levels of IL-17A. However, the observed differences could not be investigated further in the small number of patients without treatment in our study, so the results should be interpreted with caution.
In conclusion, these results suggest that the impaired immune regulation observed in patients with AChR 1 MG is associated with changes in IL-10, IL-6 and IL-4 production. We noted that poor production of IL-2 (by T resp cells) observed in patients with AChR 1 MG may influence T reg suppression capacity. Conversely, IL-21 influenced T reg suppression capacity in vitro. With these findings, AChR 1 MG can also be considered among candidate diseases for cytokine-based immunotherapy approaches.
